Nolan Ryan has a Rangers player in the Biogenesis scandal: Nelson Cruz. But he’s no to worried about losing Cruz for the stretch run. Why? ESPN Dallas reports:
Ryan said, based on his talks with MLB, the investigation is going to be a “long, drawn-out affair … I don’t know that there’s a time frame that they’re dealing with,” Ryan said. “I know that they’re in a fact-finding mode right now, so we’ll just have to wait and see how that plays out. But do I worry about losing Nellie here shortly? No, I don’t. I really think he’ll be with us and we’ll just have to see where that goes.”
If Major League Baseball really is planning on a mass suspension, I wonder if they won’t wait until the offseason. Maybe to announce it, but more likely to time things in such a way so as to ensure that suspensions begin at the start of next season rather than the middle of this one.
I mean, yes, on one level you could argue that there is unfairness either way (i.e. it’s unfair to let players who cheated continue to play now and/or it’s unfair to yank a bunch of players off rosters in the middle of a pennant race) but Major League Baseball is an organization which usually tries to take the least radical means possible. I feel like they wouldn’t want to indelibly stamp a season as The Suspension Season in midstream.
According to Jorge Castillo of the Washington Post, Nationals infielder Danny Espinosa declined to attend the team’s annual Winterfest because of his dissatisfaction with management following their trade for outfielder Adam Eaton.
A source told Castillo that Espinosa’s unhappiness stemmed from a belief that the acquisition would jeopardize his starting role in 2017. With Eaton in center field, Trea Turner will likely return to his post at shortstop, leaving Espinosa out in the cold — or, as the case may be, on the bench. The move shouldn’t come as a big surprise to Espinosa, however, as Nationals’ GM Mike Rizzo spoke to the possibility of trading the infielder or reassigning him to a utility role back in early November.
Offensively, the 29-year-old had a down year in 2016, slashing just .209/.306/.378 with 24 home runs in 601 PA. Defensively, he still profiles among the top shortstops in the National League, with eight DRS (Defensive Runs Saved) and 8.3 Def (Defensive Runs Above Average) in his seventh year with the club.
Espinosa will reach free agency after the 2017 season.
The Red Sox might be trying to move the wrong pitcher, according to the Boston Globe’s Nick Cafardo. Cafardo revealed that while the Sox have been trying to market right-hander Clay Buchholz, more teams would be interested in trades involving southpaw Drew Pomeranz.
The club appears reluctant to deal Pomeranz, especially because his price tag comes in at a cool $4.7 million to Buchholz’s $13.5 million in 2017. Those who have already expressed interest in the veteran hurlers, including the Twins, Mariners and Royals, also seem put off by Buchholz’s salary requirements as he enters his 32nd year.
Health could be another factor preventing teams from jumping to make trade offers, as Cafardo quotes an AL executive who believes the “medicals on both Pomeranz and Buchholz probably aren’t that great.” Neither pitcher suffered any major injuries during the 2016 season, though Pomeranz missed just over a week of play due to forearm soreness.
Pomeranz outperformed his fellow starter in 2016, pitching to a 3.32 ERA and career-best 9.8 K/9 through 170 2/3 innings with the Padres and Red Sox. He got off to an exceptionally strong start in San Diego, where his ERA dropped to 2.47 through the first half of the year before the Padres dealt him to Boston for minor league right-hander Anderson Espinoza. Buchholz, on the other hand, struggled with a 4.78 ERA and saw a decline in both his BB/9 and K/9 rates as he worked out a career-low 1.69 K/BB through 139 1/3 innings with the Sox.